Physician profile
Nicholas Sama
NPI 1457397036
$9,300.69
in general payments reported to CMS, 2019-2025
11 companies · $1,257 in 2025
The $1,257 reported for 2025 was less than what a typical Orthopaedic Trauma provider received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $4,834 · 2021: $2,201 · 2022: $394 · 2023: $230 · 2024: $386 · 2025: $1,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,556 · Travel and Lodging: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,555.75 |
| Travel and Lodging | $316.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acumed LLC | $6,941.66 | 2020-2022 | |
| Smith+Nephew, INC. | $714.13 | 2022-2025 | Evos, Trigen, Evos Mini |
| Ecential Robotics | $532.08 | 2025 | |
| Depuy Synthes Sales INC. | $433.22 | 2020-2024 | Monovisc, Orthovisc, Na |
| Stryker Corporation | $214.39 | 2020-2025 | Gamma, Pangea |
| Acera Surgical, INC. | $159.26 | 2025 | Restrata Wound Matrix |
| Medical Device Business Services, INC. | $148.24 | 2025 | Monovisc, Orthovisc |
| Carbofix Orthopedics INC | $68.43 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $46.03 | 2024-2025 | Exparel |
| Medtronic, INC. | $29.99 | 2024 | Intellis Adaptivestim |
| Horizon Therapeutics Plc | $13.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Sama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.